Articles

KeyBanc downgraded stock to sector-weight as it awaits "better clarity" the company's earnings trajectory.

The Harvard grad and donor used well-honed activist-investor moves to get what he wanted at the nation’s premier Ivy League school

In sickness and in health, couples marrying later in life should focus on the part of the classic vows that say "til death do us part."

One question arising from the Claudine Gay controversy: Why does anyone give money to a university with a $53 billion endowment?

The controversy over Palantir Technologies shares rages on into the new year.

Corona distributor tops profit estimates for the third quarter, but sales fall short and guidance is lowered.

These food and drink trends are poised to take off in the new year

Agilon Health's stock was suffering a record plunge toward a record low Friday, after the provider of support services for primary care physicians cut its outlooks for margin, revenue and profitability, citing medical-service expenses.

MAPS Public Benefit Corp. said Friday it raised $100 million in an oversubscribed Series A round of financing as it works to win approval from the U.S. Food and Drug Administration to become the first provider of psychedelic-assisted therapy PTSD.

Stocks outpaced gold in 2023, but the yellow metal still posted stronger annualized returns since the turn of the century.

Oil futures rose Friday, on track for weekly gains as rising tensions in the Middle East stoke fears of a wider war that could crimp crude supplies.

"He never paid the mortgage on the house because he was too young at the time."